Literature DB >> 14624195

Chlorpromazine equivalents versus defined daily doses: how to compare antipsychotic drug doses?

Claudia A W Rijcken1, Taco B M Monster, Jacobus R B J Brouwers, Lolkje T W de Jong-van den Berg.   

Abstract

Classic chlorpromazine (CPZ) equivalents can be used to chart relative antipsychotic potencies of antipsychotic drugs. Values of CPZ equivalents per drug are ambiguous in literature. In drug use evaluation studies, antipsychotic doses are frequently compared by use of the defined daily dose (DDD). The DDD is the assumed average maintenance dose per day for a drug if used for its main indication in adults. The DDD is based on review of the available older and recent literature. In this report, we evaluated discrepancy between CPZ-equivalent values and DDD-equivalent values. We plotted CPZ-equivalent values against DDD-equivalent values and performed linear regression to determine the mean relationship between the 2 methods. About 67% of the DDD-equivalent values demonstrated lower potencies for antipsychotic drug compared with CPZ-equivalent values. The slope of the regression line was 0.68 (r2 = 0.81). Because we found a great discrepancy between these 2 methods of comparing antipsychotic drug doses, we think further research is necessary to develop a standardized way of antipsychotic drug comparison.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14624195     DOI: 10.1097/01.jcp.0000096247.29231.3a

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  26 in total

1.  Functional deterioration from the premorbid period to 2 years after the first episode of psychosis in early-onset psychosis.

Authors:  Ángel Del Rey-Mejías; David Fraguas; Covadonga M Díaz-Caneja; Laura Pina-Camacho; Josefina Castro-Fornieles; Inmaculada Baeza; Ana Espliego; Jessica Merchán-Naranjo; Ana González-Pinto; Elena de la Serna; Beatriz Payá; Montserrat Graell; Celso Arango; Mara Parellada
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-03-01       Impact factor: 4.785

2.  Predictive saccades are impaired in biological nonpsychotic siblings of schizophrenia patients.

Authors:  Isabelle Amado; Steffen Landgraf; Marie-Chantal Bourdel; Sabinien Leonardi; Marie-Odile Krebs
Journal:  J Psychiatry Neurosci       Date:  2008-01       Impact factor: 6.186

3.  Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial.

Authors:  David Hui; Allison De La Rosa; Annie Wilson; Thuc Nguyen; Jimin Wu; Marvin Delgado-Guay; Ahsan Azhar; Joseph Arthur; Daniel Epner; Ali Haider; Maxine De La Cruz; Yvonne Heung; Kimberson Tanco; Shalini Dalal; Akhila Reddy; Janet Williams; Sapna Amin; Terri S Armstrong; William Breitbart; Eduardo Bruera
Journal:  Lancet Oncol       Date:  2020-05-29       Impact factor: 41.316

4.  Timing dysfunctions in schizophrenia as measured by a repetitive finger tapping task.

Authors:  Christine A Carroll; Brian F O'Donnell; Anantha Shekhar; William P Hetrick
Journal:  Brain Cogn       Date:  2009-08-06       Impact factor: 2.310

5.  Neuroanatomical deficits shared by youth with autism spectrum disorders and psychotic disorders.

Authors:  Covadonga M Díaz-Caneja; Hugo Schnack; Kenia Martínez; Javier Santonja; Yasser Alemán-Gomez; Laura Pina-Camacho; Carmen Moreno; David Fraguas; Celso Arango; Mara Parellada; Joost Janssen
Journal:  Hum Brain Mapp       Date:  2018-12-19       Impact factor: 5.038

6.  Atypical age-dependency of executive function and white matter microstructure in children and adolescents with autism spectrum disorders.

Authors:  Kenia Martínez; Jessica Merchán-Naranjo; Laura Pina-Camacho; Yasser Alemán-Gómez; Leticia Boada; David Fraguas; Carmen Moreno; Celso Arango; Joost Janssen; Mara Parellada
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-04-26       Impact factor: 4.785

7.  Evaluation of Defined Daily Dose, percentage of British National Formulary maximum and chlorpromazine equivalents in antipsychotic drug utilization.

Authors:  Waleed M Sweileh; Jihad Bani Odeh; Naser Y Shraim; Sa'ed H Zyoud; Ansam F Sawalha; Samah W Al-Jabi
Journal:  Saudi Pharm J       Date:  2013-04-06       Impact factor: 4.330

8.  Relationship between motor function and psychotic symptomatology in young-adult patients with schizophrenia.

Authors:  Shu-Mei Wang; Wen-Chen Ouyang; Ming-Yi Wu; Li-Chieh Kuo
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-04-11       Impact factor: 5.270

Review 9.  Antipsychotic-induced hyponatraemia: a systematic review of the published evidence.

Authors:  Didier Meulendijks; Cyndie K Mannesse; Paul A F Jansen; Rob J van Marum; Toine C G Egberts
Journal:  Drug Saf       Date:  2010-02-01       Impact factor: 5.606

10.  Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study.

Authors:  Rune A Kroken; Erik Johnsen; Torleif Ruud; Tore Wentzel-Larsen; Hugo A Jørgensen
Journal:  BMC Psychiatry       Date:  2009-05-16       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.